Abstract
Neuroblastoma is one of the most common malignant tumor in infants and the most common extracranial solid tumor of childhood. Despite the advances in diagnostics, the median age at diagnosis is 14 months and 50–60 % of patients will have metastatic disease when diagnosed. The clinical course of neuroblastoma and the prognosis are extremely heterogeneous and are determined primarily by the molecular genetic features of the tumor, its localization, and the presence of metastatic lesions. Precise stratification on risk groups is a key aspect for treatment choice and the possibility to avoid the toxicity of anticancer treatment in groups with favorable prognosis and to use the most intensive multimodal treatment in high and ultra-high-risk groups. We present clinical cases of neuroblastoma in pediatric patients with demonstration of anamnesis features, diagnostic algorithms and appropriate standard of care.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.